share

Inogatran CAS NO 155415-08-0


Unit Price:

CAS No.:155415-08-0

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Inogatran CAS NO 155415-08-0 is a synthetic, low molecular weight thrombin inhibitor. This compound is of significant interest in pharmaceutical research and development due to its potent and selective anticoagulant properties. It serves as a key intermediate and active pharmaceutical ingredient (API) for researchers and manufacturers developing novel antithrombotic therapies targeting cardiovascular diseases and surgical procedures.

Application

  • Pharmaceutical Intermediate: Primary use as a critical building block in the synthesis of advanced direct thrombin inhibitors (DTIs).
  • Anticoagulant Drug Development: Core active component in research for next-generation medications to prevent and treat blood clots (thrombosis).
  • Biochemical Research: A standard and selective thrombin inhibitor used in in vitro studies to understand coagulation pathways and enzyme kinetics.
  • Diagnostic Reagent Component: Potential use in the formulation of specialized diagnostic kits for monitoring coagulation status.
  • Medical Device Coatings: Investigational application for creating biocompatible, anti-thrombogenic surfaces on stents, catheters, and other implants.

Basic Information

Product Name Inogatran
CAS No. 155415-08-0
Molecular Formula C23H40N8O6
Molecular Weight 524.62 g/mol
Synonyms Inogatran; BIBR 1048; (2R,4R)-4-Methyl-1-[N2-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-L-arginyl]-2-piperidinecarboxylic acid; 1-[(3-Methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl)-L-arginyl]-4-methyl-cis-2-piperidinecarboxylic acid; BIBR-1048; Dabigatran intermediate; Direct Thrombin Inhibitor intermediate
EINECS Contact for details

Quality Control

Our Inogatran is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure identity, purity, and consistency, meeting the stringent requirements for pharmaceutical intermediates. A detailed Certificate of Analysis (COA) providing results for assay, related substances, residual solvents, and other critical parameters is supplied with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept under dry, inert conditions to maintain stability and potency.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to reference spectrum
Identification (HPLC) Retention time matches reference standard
Assay (HPLC) ≥ 98.0%
Related Substances (HPLC) Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Water Content (KF) ≤ 1.0%
Residual Solvents (GC) Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.